Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.

Keywords

Osteoblast, Bisphosphonate, Bone resorption, Chemistry, Internal medicine

References

• In vitro effect of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonic acid (APD) on the function of mononuclear phagocytes in lymphocyte proliferation.de Vries E, van der Weij, van der Veen Cj — 1982
• Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis.Dilip Amin, SA Cornell, SK Gustafson — 1992
• Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs.Helena L. Benford, Julie C. Frith, Seppo Auriola — 1999
• Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during ApoptosisAlfred A. Reszka, Judit Halasy-Nagy, P. Masarachia — 1999
• Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment.Masahiro Ito, Norio Amizuka, T Nakajima — 1999
• Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.John Fisher, Michael J. Rogers, J. M. Halasy — 1999
• Effect of alendronate on cultured normal human osteoblasts.C. García-Moreno, Sérgio Serrano, Montserrat Nacher — 1998
• Pamidronate treatment in patients with tumor-associated hypercalcemia: pharmacological effects and pharmacokinetics.Yutaka Oiso, A Tomita, H Hasegawa — 1994
• Infusion rate and pharmacokinetics of intravenous pamidronate in the treatment of tumour-induced hypercalcaemia.David Dodwell, Anthony Howell, A. Ross Morton — 1992
• PHARMACOKINETICS OF PAMIDRONATE DISODIUM IN CANCER PATIENTS AFTER A SINGLE INTRAVENOUS INFUSION OF 30‐, 60− OR 90‐mg DOSE OVER 4 OR 24 HOURSWing K. Cheung, Lane J. Brunner, Steve Schoenfeld — 1994
• Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.Masahiko Sato, W A Grasser, Naoto Endo — 1991
• Effects of two novel bisphosphonates on bone cells in vitro.C. Evans, Isobel Braidman — 1994
• Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106.Xin Yu, Jørgen Schøller, Niels T. Foged — 1996
• Effects of short‐term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatmentA. Pataki, Klaus Müller, Jonathan R. Green — 1997
• Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1.Kaoru Igarashi, Masahiko Hirafuji, H. Adachi — 1997
• Bisphosphonates: from the laboratory to the clinic and back again.R.G.G. Russell, Michael J. Rogers — 1999
• Development and characterization of a conditionally immortalized human fetal osteoblastic cell lineSteven A. Harris, Robert J. Enger, Lawrence B. Riggs — 1995
• Alendronate/Interleukin‐1β Cotreatment Increases Interleukin‐6 in Bone and UMR‐106 Cells: Dose Dependence and Relationship to the Antiresorptive Effect of AlendronateJ. L. Sanders, Gabor Tarján, Shirley A. Foster — 1998
• The Role of Geranylgeranylation in Bone Resorption and Its Suppression by Bisphosphonates in Fetal Bone Explants In Vitro: A Clue to the Mechanism of Action of Nitrogen‐Containing BisphosphonatesErmond van Beek, Clemens W.G.M. Löwik, Gabri van der Pluijm — 1999
• The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.R. Balena, Brian C. Toolan, M. Shea — 1993

Cited by

• Zoledronic acid significantly reduces pathologic fractures in patients with advanced-stage prostate cancer metastatic to bone.Дмитрий Богданов, Василий Хитрик — 2002
• The Effects of Risedronate and Exercise on Osteoporotic Lumbar Rat Vertebrae and Their Sensory InnervationSumihisa Orita, Seiji Ohtori, Takana Koshi — 2010
• Treatment of bisphosphonate-induced osteonecrosis of the jaws with Nd:YAG laser biostimulation由枝 松原, 知香 西村 — 2011
• Alendronate promotes bone formation by inhibiting protein prenylation in osteoblasts in rat tooth replantation model.Koichiro Komatsu, Akemi Shimada, Tatsuya Shibata — 2013
• Effect of bisphosphonates treatment on cytokine imbalance between TH17 and Treg in osteoporosis段汝娇, Wei Zhao, 黄松岭 — 2015
• Effect of surfactant concentration on textural characteristics and biomineralization behavior of mesoporous bioactive glasses.Anil Kumar, Anusha Aditya, Sevi Murugavel — 2019
• Bisfosfonatos e osteonecrose dos maxilaresJosé Carlos Felgueiras — 2008
• The isoprenoid biosynthesis pathway and regulation of osteoblast differentiationMegan Weivoda — 2011
• Bisphosphonate Inhibition of Prostate Cancer Cell Invasion, Migration and Cytoskeletal OrganizationSanna Virtanen — 2010
• Pharmacotherapy of Paget’s Disease of Bone: Focus on Zoledronic AcidΚωνσταντίνος Τζιόμαλος, Vasilios G. Athyros, Asterios Karagiannis — 2009
• Effect of Zoledronate on Bone Quality in the Treatment of Aseptic Loosening of Hip Arthroplasty in the DogLyn M. Wise, Stephen D. Waldman, Mehran Kasra — 2005
• Effects of Bisphosphonates on the Proliferation and the Alkaline Phosphatase Activity of Human Bone Marrow Derived Mesenchymal Stem CellsJunho Jung, Baek‐Soo Lee, Yong‐Dae Kwon — 2011
• Novel perspectives to improve the outcome of bone impaction grafting in revision surgery of total hip arthroplastiesNina M.C. Mathijssen — 2014
• Histochemical evidence of zoledronate inhibiting c-src expression and interfering with CD44/OPN-mediated osteoclast adhesion in the tibiae of miceHongrui Liu, Jian Cui, Jing Sun — 2015
• Modifications de la composition et de la structure moléculaire du tissu osseux sous l'influence des bisphosphonatesC. Olejnik — 2014
• Surface modification of titanium and titanium alloys to enhance bone healingYasmeen Janzeer — 2013
• Drug delivery to the bone-implant interface: Functional hydroxyapatite surfaces and particlesAndrea Schüssele — 2007
• Enhanced Anchorage of Tissue-Engineered Cartilage Using an Osteoinductive ApproachRupak Dua — 2014
• Перспективные направления терапии остеоартрозаЛ. И. Алексеева, Elena Zaitseva — 2014
• Enhancing Quality of Life for Breast Cancer Patients with Bone MetastasesSarah A. Arrington — 2007

Related papers

• Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.Dutmanee Seriwatanachai, Kanogwun Thongchote, Narattaphol Charoenphandhu — 2008
• In vitro and in vivo effects of adiponectin on bone.Garry A Williams, Yu Wang, Karen E. Callon — 2009
• Parathyroid hormone increases the expression of receptors for epidermal growth factor in UMR 106-01 cells.Matthew T. Drake, Joseph J. Baldassare, Charles L. McConkey — 1994
• Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice.Dengshun Miao, Jiarong Li, Yingben Xue — 2004
• Serum leptin levels, bone mineral density and osteoblast alkaline phosphatase activity in elderly men and women.John K Scariano — 2003
• Chronic Mild Stress Causes Bone Loss via an Osteoblast-Specific Glucocorticoid-Dependent MechanismHolger Henneicke, Jingbao Li, Sarah Kim — 2017
• Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.Sergiu Boțolin, Marie–Claude Faugere, Hartmut H. Malluche — 2005
• Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone.Thomas L. McCarthy, Ernesto Canalis — 1989
• Energy regulation by the skeleton.George Wolf — 2008